Leucine Aminopeptidase to Spleen Length Ratio: A Novel Noninvasive Model for Predicting Esophageal Gastric Variceal Bleeding in Patients With Liver Cirrhosis.

Key Points

• To explore the effectiveness of leucine aminopeptidase to spleen length ratio in predicting bleeding risk.
• Analyzed leucine aminopeptidase levels and spleen length in patients with liver cirrhosis.
• Evaluated the predictive capacity for esophageal gastric variceal bleeding.
• Assessed the combination of leucine aminopeptidase ratio and total protein levels.
• Leucine aminopeptidase to spleen length ratio showed a significant correlation with bleeding events.
• Combination with total protein enhanced predictive accuracy for bleeding in these patients.